Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial
Authors
Sofia Amylidi‐Mohr (ORCID: https://orcid.org/0000-0001-5996-4064)
Daniel Surbek (ORCID: https://orcid.org/0000-0001-7705-1584)
Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial
Sofia Amylidi‐Mohr, Daniel Surbek, Beatrice Mosimann, S Schneider et al.
Citations
14 citations
Journal
The Lancet Diabetes & Endocrinology
Topics
Gestational Diabetes Research and Management
Field-Weighted Citation Impact (FWCI)
28.80
article
Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial
Sofia Amylidi‐Mohr, Daniel Surbek, Beatrice Mosimann, S Schneider, Luigi Raio, Giulia Zennaro
article en
14 citations
Abstract
No abstract available for this paper.
Publication Tag
The Lancet Diabetes & EndocrinologyVol. 13(7)
Institutions
University Hospital of Bern (CH), University Hospital of Basel (CH)